Enabling absolute quantitation of APOE4, BD-pTau217, Aβ42, GFAP, and NfL in a single multiplexed assay.
On closing the gap between molecular measurement & clinical meaning, rapidly extracting actionable biological signals.
PharmaShots delves into Sapient’s mission to transform multi-omics research through innovation & world-class partnerships.
Enabling measure of 10K+ proteins in FFPE tissue & tumors and multi-omic molecular mapping of tumor biology.
The innovations enhance how MS data is processed, filtered & interpreted across large-scale biological datasets.
Bridging the gap from large-scale omics data generation to deep characterization of disease & treatment biomarkers.
Detailing the rLC-MS method & its use to predict clinically relevant physiological states at scale in human populations.
Exploring key innovations have converged to transform the utility of proteomics in drug discovery & development.
See why DynamiQ is among the most deeply phenotyped datasets available for longitudinal analysis in drug development.
This multi-omics study, led by UPitt researchers, establishes causative linkages between key metabolites & PAH.
See how the partnership complements Sapient’s mass spectrometry-based proteomics & multi-omics services.
Dr. Jonathan Usuka appointed Chief Executive Officer as Founder Dr. Mohit Jain transitions to Chief Scientific Officer.
